Determinants of Tenascin-C and HIV-1 envelope binding and neutralization.

TitleDeterminants of Tenascin-C and HIV-1 envelope binding and neutralization.
Publication TypeJournal Article
Year of Publication2019
AuthorsMangan RJ, Stamper L, Ohashi T, Eudailey JA, Go EP, Jaeger FH, Itell HL, Watts BE, Fouda GG, Erickson HP, S Alam M, Desaire H, Permar SR
JournalMucosal Immunol
Volume12
Issue4
Pagination1004-1012
Date Published2019 Jul
ISSN1935-3456
KeywordsAmino Acid Sequence, Amino Acids, env Gene Products, Human Immunodeficiency Virus, Epitope Mapping, Epitopes, Glycosylation, HIV Envelope Protein gp120, HIV-1, Humans, Models, Molecular, Neutralization Tests, Peptide Fragments, Protein Binding, Protein Conformation, Protein Interaction Domains and Motifs, Protein Multimerization, Recombinant Proteins, Tenascin
Abstract

Interactions between innate antiviral factors at mucosal surfaces and HIV-1 virions contribute to the natural inefficiency of HIV-1 transmission and are a platform to inform the development of vaccine and nonvaccine strategies to block mucosal HIV-1 transmission. Tenascin-C (TNC) is a large, hexameric extracellular matrix glycoprotein identified in breast milk and genital fluids that broadly neutralizes HIV-1 via interaction with the HIV-1 Envelope (Env) variable 3 (V3) loop. In this report, we characterize the specific determinants of the interaction between TNC and the HIV-1 Env. We observed that TNC binding and neutralization of HIV-1 is dependent on the TNC fibrinogen-like globe (fbg) and fibronectin-type III (fn) domains, oligomerization, and its newly-mapped glycan structure. Moreover, we observed that TNC-mediated neutralization is also dependent on Env V3 residues 321/322 and 326/327, which surround the IGDIR motif of the V3 loop, as well the N332 glycan, which is critical to the broadly neutralizing activity of glycan-dependent V3-specific antibodies such as PGT128. Our results demonstrate a striking parallel between innate and adaptive immune mechanisms of broad HIV neutralization and provide further insight into the host protein-virus interactions responsible for the natural inefficiency of mucosal HIV-1 transmission.

DOI10.1038/s41385-019-0164-2
Alternate JournalMucosal Immunol
PubMed ID30976088
PubMed Central IDPMC6599478
Grant ListUM1 AI100645 / AI / NIAID NIH HHS / United States
R01 AI125093 / AI / NIAID NIH HHS / United States
R01 GM103547 / GM / NIGMS NIH HHS / United States
R01 DE025444 / DE / NIDCR NIH HHS / United States
R01 AI106380 / AI / NIAID NIH HHS / United States